NEW YORK, Oct. 25, 2017 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Tesla, Inc. ("Tesla") (NASDAQ:TSLA) between May 4, 2016 and October 6, 2017. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Northern District of California. To get more information go to:
http://www.zlk.com/plsra-c/tesla-inc?wire=3
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) contrary to defendants’ representations, Tesla had severely inadequate inventory and was woefully unprepared to launch its Model 3 sedan as anticipated; and (2) as a result, Tesla’s public statements were materially false and misleading at all relevant times.
If you suffered a loss in Tesla you have until December 11, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com


Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue
FCC Exempts Select Foreign-Made Drones From U.S. Import Ban Until 2026
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom
xAI Cash Burn Highlights the High Cost of Competing in Generative AI
Ford Targets Level 3 Autonomous Driving by 2028 with New EV Platform and AI Innovations
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S.
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026
Chevron Seeks Expanded U.S. License to Boost Venezuelan Oil Exports Amid Sanctions Talks
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S.
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content 



